An ambitious plan to sequence genomes for 1.85 million eukaryotic species on our planet is underway. It's a massive ...
(Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an improved framework ...
Cogent Biosciences, Inc. stock soars after bezuclastinib's strong Phase 3 results in GIST. Click for my updated look at COGT ...
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with: £86bn to fund everything from new drug treatments and longer-lasting ...